Why I, as an undergraduate student studying science, enjoyed this conversation In Illumina’s SPARK 2021 Conference (April 26-27, 2021), Frances Arnold and Jennifer Doudna discuss the joys, challenges, and ethics of gene...read more
Latest news and articles
Enlightenbio Releases New Report: Warehousing Clinical & Genomics Biomedical Data – A Needs & Challenges Analysis Report
New, critical, investigative, and qualitative report analyzes the observations and learnings across the complex components of biomedical data warehousing, querying, and collaboration. Palo Alto, CA, May 13...read more
FAIR Data or the Journey Towards Data-Centricity – Pushing Towards Making Data Discoverable, Accessible, Interoperable, and Reusable
Data is the blood being pumped through the organism of personalized medicine and will be – as has always been – the key to the identification of novel biomarkers and potential new therapeutics. We have never...read more
The Medical Research Community Has a Duty to Be Racially And Ethnically Inclusive in Their Study Demographics
I am currently a third year undergraduate student at Emory University studying Biology and Religion while on the pre-med track. I am also presently the Digital Marketing and Communications Intern at enlightenbio due to...read more
Enlightenbio Releases New Clinical Genomics Report: The Interplay Between Clinical Research & Clinical Diagnostics
New, qualitative report provides an in-depth analysis across the complex, multi-step clinical genomics data process, including genomic data generation and analysis, data flow, and data warehousing. Palo Alto, CA...read more
The Promise and Hope of RNA-based vaccines for COVID-19
The worldwide devastation wrought by the COVID-19 pandemic is well known to everyone, as is the resulting push to develop effective vaccines and therapies that have been proceeding on a massive scale and at rapid pace...read more
Bluebee’s coherent data strategy set to unify Illumina’s data analytics products
This month’s attention-grabbing headlines in the field of genomics, genetics, and precision medicine can undoubtedly be attributed to the acquisition of Bluebee by Illumina. I spoke with Hans Cobben, CEO of Bluebee and...read more
Gene Editing Revamped with CRISPR Prime Editor – Result Is A High Efficiency, More Precise Gene Editor With Versatile Editing Capabilities And Lower Off-Target Effects
In October 2018 we published a blog (CRISPR Base Editors: An Upgrade for Treatment of Genetic Disease) describing some of the concerns surrounding the use of the CRISPR technology, and highlighting a relatively new...read more
Real World Evidence is not simply a buzzword anymore in our fast-paced world of health technology
Over the last several years, various technology experts have been discussing how the impact of big data, machine learning, and artificial intelligence will affect our daily lives – from what we buy online to how...read more
An interview with Michael Snyder, Stanford W. Ascherman Professor and Chair, Department of Genetics & Director, Center for Genomics and Personalized Medicine
The following is an interview I recently conducted for the PMWC Intl. team with Dr. Mike Snyder, Professor of Genetics at Stanford University, and in essence is a repost of the original interview that can be found on...read more
